DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tocainide
Tocainide
A Proposal for the Clinical Use of Flecainide
Second Generation Antiarrhythmic Agents: Have We Reached Antiarrhythmic Nirvana?
Ventricular Tachycardia Drugs Versus Devices John Camm St
Draft for Public Comment
Voltage-Gated Sodium Channels and Blockers: an Overview and Where Will They Go?*
Prescription Medications, Drugs, Herbs & Chemicals Associated With
Drugs That Affect the Cardiovascular System
Table of Common Heart Medications
Dysarthria and Visual Hallucinations Due to Flecainide Toxicity
Ibm Micromedex® Carenotes Titles by Category
Combined Anti-Arrhythmic Therapywith Class 1 and Class 3 Drugs
2021 Equine Prohibited Substances List
Neuropathic Pain Therapeutic Class Review
The Hitchhiker's Guide to Clinical Pharmacology
Problems of Drug Dependence 1989: Proceedings of the 51St Annual
Therapeutic Class Overview Neuropathic Pain Agents
Repurposing Drugs for COVID-19 Based on Transcriptional Response of Host Cells to SARS-Cov-2
Managing-Pain.Pdf
Top View
Management of Drug Overdose and Poisoning
Case Reports Case Reports
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary Data Table S1. Known Drugs Containing Aryl Amine, Amide
Tocainide Hydrochloride | Medchemexpress
Increased Sodium Channel Use-Dependent Inhibition by a New Potent Analogue of Tocainide Greatly Enhances in Vivo Antimyotonic Activity
Particular Reference to Class I Antiarrhythmic Agents
Supplementary Table 1: List of Drugs and Their Binding Energies to ACE and ACE2
Ocm25045515.Pdf (2.108Mb)
Therapeutic Class Overview Neuropathic Pain Agents
Arxiv:1810.00701V1 [Physics.Bio-Ph] 1 Oct 2018 ∗ Lsn H Oewe Eurd3.Teincanl Are Channels Ion the by Required[3]
Review of Pharmacotherapy for Tinnitus
(12) United States Patent (10) Patent No.: US 8,697,361 B2 Johnson (45) Date of Patent: Apr
Lidocaine Patch Literature Review
Winek's Drug & Chemical Blood-Level Data 2001